RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53.

MLA

Jacquier, Valentin, et al. “RIP140 Inhibits Glycolysis-Dependent Proliferation of Breast Cancer Cells by Regulating GLUT3 Expression through Transcriptional Crosstalk between Hypoxia Induced Factor and P53.” Cellular and Molecular Life Sciences : CMLS, vol. 79, no. 5, May 2022, p. 270. EBSCOhost, https://doi.org/10.1007/s00018-022-04277-3.

APA

Jacquier, V., Gitenay, D., Fritsch, S., Bonnet, S., Győrffy, B., Jalaguier, S., Linares, L. K., Cavaillès, V., & Teyssier, C. (2022). RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53. Cellular and Molecular Life Sciences : CMLS, 79(5), 270. https://doi.org/10.1007/s00018-022-04277-3

Chicago

Jacquier, Valentin, Delphine Gitenay, Samuel Fritsch, Sandrine Bonnet, Balázs Győrffy, Stéphan Jalaguier, Laetitia K Linares, Vincent Cavaillès, and Catherine Teyssier. 2022. “RIP140 Inhibits Glycolysis-Dependent Proliferation of Breast Cancer Cells by Regulating GLUT3 Expression through Transcriptional Crosstalk between Hypoxia Induced Factor and P53.” Cellular and Molecular Life Sciences : CMLS 79 (5): 270. doi:10.1007/s00018-022-04277-3.